Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis

J Med Virol. 2009 May;81(5):933-6. doi: 10.1002/jmv.21444.

Abstract

Poliovirus infections can be asymptomatic or cause severe paralysis. Why some individuals develop paralytic poliomyelitis is unknown, but a role for host genetic factors has been suggested. To investigate if a polymorphism, Ala67Thr, in the poliovirus receptor, which has been found to facilitate increased resistance against poliovirus-induced cell lysis and apoptosis, is associated with increased risk of paralytic poliomyelitis, poliovirus receptor genotyping was undertaken among Italian subjects with vaccine-associated (n = 9), or with wild-type paralytic poliomyelitis (n = 6), and control subjects (n = 71), using RFLP-PCR and pyrosequencing. Heterozygous poliovirus receptor Ala67Thr genotype was found in 13.3% of the patients with paresis and in 8.5% of the controls (Odds Ratio = 1.667). The frequency of Ala67Thr among the controls is in agreement with earlier published data. It is concluded that the Ala67Thr mutation in the poliovirus receptor is a possible risk factor for the development of vaccine-associated or paralytic poliomyelitis associated with wild-type virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Female
  • Genotype
  • Humans
  • Infant
  • Italy
  • Male
  • Middle Aged
  • Mutation*
  • Paralysis / genetics*
  • Paralysis / virology*
  • Poliomyelitis / complications
  • Poliomyelitis / genetics*
  • Poliomyelitis / virology
  • Poliovirus / pathogenicity*
  • Poliovirus Vaccine, Oral / adverse effects*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Receptors, Virus / genetics*
  • Risk Factors
  • Sequence Analysis, DNA / methods
  • Young Adult

Substances

  • Poliovirus Vaccine, Oral
  • Receptors, Virus
  • poliovirus receptor